Release Date: 22/08/19 18:59 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 3.55MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%